E7389 (eribulin)

eribulin · Eisai Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for E7389 (eribulin), covering 2011-12-20 to 2011-12-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Clinical Study of E7389 [Phase 1]